The People of Tulane Cancer Center Research

Krzysztof MorozKrzysztof Moroz, M.D.
Professor of Pathology
Section of Surgical Pathology & Cytopathology
Director of Cytopathology Fellowship Program
Head, Cytology Laboratory
Co-Director, Biospecimen Core Laboratory, Louisiana Cancer Research Consortium
Tulane Cancer Contributing Member

Contact Information
Phone: 504-988-5224
Address: 1430 Tulane Ave., Box SL-79, New Orleans, LA 70112-2699

Biographical Narrative
Dr. Moroz received his MD from the Academy of Medicine in Bialystok, Poland. He completed his anatomic pathology training at the Mallory Institute of Pathology, Boston University School of Medicine in Boston, followed by clinical pathology training at the University Hospital at Boston University School of Medicine. Dr. Moroz completed fellowship training in cytopathology at the Mallory Institute of Pathology at Boston University School of Medicine in 1994. He is board-certified in anatomic and clinical pathology (1993) and cytopathology (1994) by the American Board of Pathology. He is a fellow of the College of American Pathologists. Dr. Moroz joined Tulane University School of Medicine in 1994. He is actively participating in the cytopathology and surgical pathology services of the department. His research interests include breast and prostate cancer, and prognostic tumor markers. He is co-directing the Biospecimen Core Laboratory of the Louisiana Cancer Research Consortium.

Recent Publications
Bao L, Chandra PK, Moroz K, Zhang X, Thung SN, Wu T, Dash S. Impaired autophagy response in human hepatocellular carcinoma. Exp Mol Pathol. 2013 Dec 23. pii: S0014-4800(13)00148-2. doi: 10.1016/j.yexmp.2013.12.002. [Epub ahead of print]

Abd Elmageed ZY, Moroz K, Kandil E. Clinical significance of CD146 and latexin during different stages of thyroid cancer. Mol Cell Biochem. 2013 Sep;381(1-2):95-103. doi: 10.1007/s11010-013-1691-x. Epub 2013 May 28.

Abd Elmageed ZY, Moroz K, Srivastav SK, Fang Z, Crawford BE, Moparty K, Thomas R, Abdel-Mageed AB. High Circulating Estrogens and Selective Expression of ERβ in Prostate Tumors: Implications for Racial Disparity of Prostate Cancer. Carcinogenesis. 2013 May 8. [Epub in process]

Moroz K. What is the recommended use of p16 immunostaining as an adjunct diagnostic biomarker in HPV-associated lesions of the lower anogenital tract? CAP Today. March 2013:66-67.

Miller S, Bhasin N, Urrego H, Moroz K, Rowan BG, Ramayya MS, Makridakis NM. Genetic and epigenetic alterations of steroidogenic factor‑1 in ovarian tumors. <> Int J Oncol. 2013 Feb;42(2):627-34.

Marsden CG, Wright MJ, Carrier L, Moroz K, Rowan BG. Disseminated Breast Cancer Cells Acquire a Highly Malignant and Aggressive Metastatic Phenotype during Metastatic Latency in the Bone. <> PLoS One. 2012;7(11):e47587. doi: 10.1371/journal.pone.0047587. Epub 2012 Nov 15.

Stolier A, Stone JC, Moroz K, Hanemann CW, McNabb L, Jones SD, Lacey M. A Comparison of Clinical and Pathologic Assessments for the Prediction of Occult Nipple Involvement in Nipple-Sparing Mastectomies. <> Ann Surg Oncol. 2013 Jan;20(1):128-32.

Gagliardi G, Moroz K, Bellows CF. Immunolocalization of DCAMKL-1, a putative intestinal stem cell marker, in normal colonic tissue. Pathol Res Pract. 2012 Aug 15;208(8):475-9. Epub 2012 Jun 30.

Bao L, Hazari S, Mehra S, Kaushal D, Moroz K, Dash S. Increased Expression of P-Glycoprotein and Doxorubicin Chemoresistance of Metastatic Breast Cancer Is Regulated by miR-298. Am J Pathol. 2012 Apr 18.

Anbalagan M, Moroz K, Ali A, Carrier L, Glodowski S, Rowan BG. Subcellular localization of total and activated SRC kinase in African American and Caucasian breast cancer. PLoS One. 2012;7(3):e33017. Epub 2012 Mar 22.

Ramayya MS, Sheng M, Moroz K, Hill SM, Rowan BG. Human Steroidogenic Factor-1 (hSF-1) Regulates Progesterone Biosynthesis and Growth of Ovarian Surface Epithelial Cancer Cells. The Journal of Steroid Biochemistry and Molecular Biology 2010 Mar;119(1-2):14-25. Epub 2010 Jan 4.

Kandil E, King S, Alabbas H, Moroz K, Wright M. Image of the month. Small-bowel metastasis from infiltrating lobular breast cancer. Arch Surg. 2009 Oct;144(10):973-974.

Kandil E, King S, Alabbas H, Moroz K, Wright M.Image of the month--Quiz Case. Arch Surg. 2009 Oct;144(10):973

Winters R, Moroz K, Friedlander P. Pathology quiz case 1. Schwannoma with ancient change. Arch Otolaryngol Head Neck Surg. 2008, 134(9):1012 -1014.

Takei H, Florez L, Moroz K, Bhattacharjee MB. Medulloepithelioma: Two unusual locations. Pathology International 2007, 57:91-95

Jing X, David O, Moroz K. Cytologic diagnosis of small cell variant of squamous cell carcinoma and its differential diagnosis. 2006 CheckSample C06-2 (C-380), ASCP 2006


1430 Tulane Ave, New Orleans, LA 70112